Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) and Icon (NASDAQ:ICLR – Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.
Risk and Volatility
Rapid Micro Biosystems has a beta of 1.52, indicating that its share price is 52% more volatile than the S&P 500. Comparatively, Icon has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500.
Earnings & Valuation
This table compares Rapid Micro Biosystems and Icon”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Rapid Micro Biosystems | $33.59 million | 1.10 | -$47.12 million | ($1.09) | -0.68 |
| Icon | $8.25 billion | 1.76 | $229.34 million | $5.81 | 32.68 |
Icon has higher revenue and earnings than Rapid Micro Biosystems. Rapid Micro Biosystems is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Rapid Micro Biosystems and Icon’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Rapid Micro Biosystems | -138.24% | -211.25% | -77.03% |
| Icon | 5.45% | 7.73% | 4.39% |
Analyst Ratings
This is a breakdown of current ratings for Rapid Micro Biosystems and Icon, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Rapid Micro Biosystems | 1 | 2 | 1 | 0 | 2.00 |
| Icon | 1 | 9 | 9 | 1 | 2.50 |
Rapid Micro Biosystems currently has a consensus target price of $1.81, indicating a potential upside of 145.93%. Icon has a consensus target price of $213.76, indicating a potential upside of 12.60%. Given Rapid Micro Biosystems’ higher probable upside, equities analysts plainly believe Rapid Micro Biosystems is more favorable than Icon.
Insider & Institutional Ownership
52.6% of Rapid Micro Biosystems shares are held by institutional investors. Comparatively, 95.6% of Icon shares are held by institutional investors. 12.7% of Rapid Micro Biosystems shares are held by insiders. Comparatively, 44.0% of Icon shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Icon beats Rapid Micro Biosystems on 13 of the 15 factors compared between the two stocks.
About Rapid Micro Biosystems
Rapid Micro Biosystems develops automated microbial detection systems for pharmaceutical, biotechnology and other life sciences manufacturers. Its products are designed to support quality-control testing by identifying and measuring microbial growth in manufacturing environments and products. The company’s Growth Direct platform combines laboratory instruments, consumables and software to automate microbial testing. Its applications include sterility testing, bioburden testing and environmental monitoring, helping manufacturers assess contamination during production.
About Icon
ICON plc is a global contract research organization (CRO) that provides outsourced development services to pharmaceutical, biotechnology, medical device and government organizations. Its work supports the development of medicines and other healthcare products from early research through clinical trials and regulatory submission. The company’s services include clinical trial design and management, data management and biostatistics, regulatory support, laboratory services, medical imaging and patient recruitment.
Receive News & Ratings for Rapid Micro Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rapid Micro Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
